Statin Use Associates With Risk of Type 2 Diabetes via Epigenetic Patterns at ABCG1

Statin is the medication most widely prescribed to reduce plasma cholesterol levels. Yet, how the medication contributes to diabetes risk and impaired glucose metabolism is not clear. This study aims to examine the epigenetic mechanisms of ABCG1 through which statin use associates with risk of type...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuwei, Shen, Yu, Guo, Tao, Parnell, Laurence D., Westerman, Kenneth E., Smith, Caren E., Ordovas, Jose M., Lai, Chao-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308584/
https://www.ncbi.nlm.nih.gov/pubmed/32612641
http://dx.doi.org/10.3389/fgene.2020.00622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308584/
https://www.ncbi.nlm.nih.gov/pubmed/32612641
http://dx.doi.org/10.3389/fgene.2020.00622

Ejemplares similares